Thrombotic Microangiopathy in Inverted Formin 2–Mediated Renal Disease-Reference-Cited by-同舟云学术

Thrombotic Microangiopathy in Inverted Formin 2–Mediated Renal Disease

Published:2016-12-14 Issue:4 Volume:28 Page:1084-1091
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Challis Rachel C.,Ring Troels,Xu Yaobo,Wong Edwin K.S.,Flossmann Oliver,Roberts Ian S.D.,Ahmed Saeed,Wetherall Michael,Salkus Giedrius,Brocklebank Vicky,Fester Julian,Strain Lisa,Wilson Valerie,Wood Katrina M.,Marchbank Kevin J.,Santibanez-Koref Mauro,Goodship Timothy H.J.,Kavanagh David

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference58 articles.

1. Atypical Hemolytic Uremic Syndrome

2. Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

3. Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome

4. DGKE Variants Cause a Glomerular Microangiopathy That Mimics Membranoproliferative GN

5. Genetic Variants in C5 and Poor Response to Eculizumab

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adeno-associated virus–based gene therapy treats inflammatory kidney disease in mice;Journal of Clinical Investigation;2024-08-15

2. Management of pediatric hemolytic uremic syndrome;The Turkish Journal of Pediatrics;2024-02-28

3. Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study;Blood;2023-10-19

4. Dysregulation of Immune Cell Subpopulations in Atypical Hemolytic Uremic Syndrome;International Journal of Molecular Sciences;2023-06-11

5. Microangiopatías trombóticas;Medicine - Programa de Formación Médica Continuada Acreditado;2023-06